Vinylbital

DB13770

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 224.26
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

665 Data
Buprenorphine Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Hydrocodone Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Magnesium sulfate The therapeutic efficacy of Vinylbital can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Vinylbital may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Mirtazapine Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Orphenadrine Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Pramipexole Vinylbital may increase the sedative activities of Pramipexole.
Ropinirole Vinylbital may increase the sedative activities of Ropinirole.
Rotigotine Vinylbital may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Vinylbital.
Suvorexant Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Thalidomide Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Vinylbital.
Sodium oxybate Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Ethanol Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Fluvoxamine The risk or severity of adverse effects can be increased when Vinylbital is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Vinylbital is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Vinylbital is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Vinylbital is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Vinylbital is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Vinylbital is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Vinylbital is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Vinylbital is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Vinylbital is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Vinylbital is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Vinylbital is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Vinylbital is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Vinylbital is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Vinylbital is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Vinylbital is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Vinylbital is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Vinylbital is combined with Alaproclate.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Vinylbital.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Vinylbital.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Vinylbital.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Vinylbital.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Vinylbital.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Vinylbital.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Vinylbital.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Vinylbital.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Vinylbital.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Vinylbital.
Dosulepin The risk or severity of CNS depression can be increased when Dosulepin is combined with Vinylbital.
Zopiclone The risk or severity of adverse effects can be increased when Vinylbital is combined with Zopiclone.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Vinylbital.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Vinylbital.
Tryptophan The risk or severity of CNS depression can be increased when Tryptophan is combined with Vinylbital.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.
Lorazepam The risk or severity of CNS depression can be increased when Lorazepam is combined with Vinylbital.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Vinylbital.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Vinylbital.
Reserpine The risk or severity of CNS depression can be increased when Reserpine is combined with Vinylbital.
Eletriptan The risk or severity of CNS depression can be increased when Eletriptan is combined with Vinylbital.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Vinylbital.
Temazepam The risk or severity of CNS depression can be increased when Temazepam is combined with Vinylbital.
Reboxetine The risk or severity of CNS depression can be increased when Reboxetine is combined with Vinylbital.
Butabarbital The risk or severity of CNS depression can be increased when Butabarbital is combined with Vinylbital.
Butalbital The risk or severity of CNS depression can be increased when Butalbital is combined with Vinylbital.
Methysergide The risk or severity of CNS depression can be increased when Methysergide is combined with Vinylbital.
Cabergoline The risk or severity of CNS depression can be increased when Cabergoline is combined with Vinylbital.
Phenytoin The risk or severity of CNS depression can be increased when Phenytoin is combined with Vinylbital.
Topiramate The risk or severity of CNS depression can be increased when Topiramate is combined with Vinylbital.
Clemastine The risk or severity of CNS depression can be increased when Clemastine is combined with Vinylbital.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Vinylbital.
Etomidate The risk or severity of CNS depression can be increased when Etomidate is combined with Vinylbital.
Morphine The risk or severity of CNS depression can be increased when Morphine is combined with Vinylbital.
Talbutal The risk or severity of CNS depression can be increased when Talbutal is combined with Vinylbital.
Pentobarbital The risk or severity of CNS depression can be increased when Pentobarbital is combined with Vinylbital.
Valproic acid The risk or severity of CNS depression can be increased when Valproic acid is combined with Vinylbital.
Zolmitriptan The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Vinylbital.
Codeine The risk or severity of CNS depression can be increased when Codeine is combined with Vinylbital.
Dihydroergotamine The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Vinylbital.
Tolcapone The risk or severity of CNS depression can be increased when Tolcapone is combined with Vinylbital.
Hydromorphone The risk or severity of CNS depression can be increased when Hydromorphone is combined with Vinylbital.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Vinylbital.
Cetirizine The risk or severity of CNS depression can be increased when Cetirizine is combined with Vinylbital.
Protriptyline The risk or severity of CNS depression can be increased when Protriptyline is combined with Vinylbital.
Trimethadione The risk or severity of CNS depression can be increased when Trimethadione is combined with Vinylbital.
Clobazam The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Vinylbital.
Chlorzoxazone The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Vinylbital.
Clozapine The risk or severity of CNS depression can be increased when Clozapine is combined with Vinylbital.
Meprobamate The risk or severity of CNS depression can be increased when Meprobamate is combined with Vinylbital.
Thiethylperazine The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Vinylbital.
Palonosetron The risk or severity of CNS depression can be increased when Palonosetron is combined with Vinylbital.
Sulpiride The risk or severity of CNS depression can be increased when Sulpiride is combined with Vinylbital.
Alprazolam The risk or severity of CNS depression can be increased when Alprazolam is combined with Vinylbital.
Dexbrompheniramine The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Vinylbital.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Bykonox
  • Speda

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul